I  Louisiana Emerging Technology Center


     Office Locations:

LSU Campus
340 East Parker, Building 340
Baton Rouge, LA 70803
Phone: 225-615-8901
Fax: 225-615-8910

Get all office locations for this firm with a National Database subscription.


  • Early
  • Seed



  • Food & Agriculture
  • Life Sciences & Healthcare



    The Louisiana Emerging Technology Center (LETC) was designed specifically as an incubator for companies with wet-lab needs and serves small and start-up businesses developing and commercializing university technologies. The 60,000 square foot facility opened in 2005 and focuses on the biotechnology, life sciences, agricultural and environmental industries. Beyond lab and office space, tenants receive business and technical assistance such as access to funding sources, legal resource and professional consulting, administrative staff and services, plus the ambiance of an established company. The LSU System Research and Technology Foundation is the parent entity of the LETC. The Foundation is backed by a broad array of government, business, and academic leaders throughout Louisiana and with their support, the Foundation developed Louisiana Fund I (see profile), an early stage venture fund for new and emerging technology companies.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Arthur R. Cooper Executive Director
    Charlotte Smith Executive Assistant
    Joseph F. Lovett Managing Director
    Kenneth Moreau Building Manager
    Sandy Deslatte Marketing Director


    Portfolio companies include:

        web link

      Esperance Pharmaceuticals
        web link

        web link

        web link

        web link

      Qyntessa Biologics
        web link

        web link

      U.S. Antigens
        web link


    Recent News: